Common side effects by frequency
| Side effect | Typical range* | Usual management |
|---|---|---|
| Nausea | ~25-30% | Smaller meals, slower titration, hydration |
| Diarrhea | ~19-23% | Fluids; clinician review if persistent |
| Constipation | ~11-17% | Fiber, fluids, activity |
| Vomiting | ~8-13% | Avoid large/fatty meals; pause titration if severe |
| Injection-site reaction | Uncommon | Rotate sites; usually mild |
*Approximate; individual experience varies. Source: SURMOUNT-1 / prescribing information.
Serious but less common risks
Labeling flags potential pancreatitis, gallbladder problems, kidney issues from dehydration, low blood sugar (especially with other diabetes medicines), and the rodent-based thyroid tumor warning. It is not recommended for people with a personal or family history of medullary thyroid carcinoma or MEN 2. These are reasons to be evaluated by a clinician rather than self-prescribing.
Why titration is your main tool
Because side effects track with dose escalation, the starter schedule (2.5 mg, rising every ~4 weeks) exists largely to build tolerance. Rushing doses tends to worsen nausea. See our dosing schedule and timeline for how the schedule works.
When to contact your clinician
Most gastrointestinal effects are manageable at home, but some symptoms warrant prompt attention: severe or persistent abdominal pain (especially radiating to the back, a possible sign of pancreatitis), signs of gallbladder trouble, persistent vomiting with dehydration, or symptoms of low blood sugar if you also take insulin or a sulfonylurea. Do not push through severe symptoms or double up doses to "catch up." When in doubt, pause and call your prescriber.
Do side effects predict weight loss?
A common myth is that more nausea means more weight loss. The evidence does not support a strong link — many people lose substantial weight with mild or no nausea, and enduring severe side effects offers no bonus. A tolerable dose you can sustain for months beats an intolerable one you abandon. Work with your clinician to find that balance.
Compounded-specific cautions
Beyond the drug’s own effects, compounded tirzepatide adds risks from multi-dose vial dosing errors and variable quality — a driver of the adverse-event reports the FDA has logged. See our safety alert. If side effects are severe or unusual, stop and contact a clinician.
Practical ways to reduce side effects
Beyond slow titration, several habits help. Eating smaller, lower-fat meals and stopping when comfortably full reduces nausea, since the medication already slows stomach emptying. Staying hydrated helps with both nausea and constipation, and gentle fiber plus activity addresses constipation directly. Many people find that spacing the dose away from large or rich meals eases the first day or two after injecting. If a particular dose step is consistently rough, clinicians can extend it before moving up. None of this should involve simply enduring severe symptoms — persistent vomiting, dehydration, or severe pain are signals to call a clinician, not to push through.
Frequently asked questions
What are the most common tirzepatide side effects?
Gastrointestinal effects — nausea, diarrhea, constipation, and vomiting — usually mild to moderate and most frequent during dose increases.
How long do side effects last?
For most people they ease after the body adjusts to each dose. Slower titration and dietary tweaks help; persistent or severe symptoms warrant clinician review.
Are there serious risks?
Labeling includes a boxed warning about thyroid C-cell tumors seen in rodents (human relevance not established), plus risks such as pancreatitis and gallbladder issues.
Do compounded versions have the same side effects?
They can, plus added risks from dosing errors with multi-dose vials and variable quality, since compounded products are not FDA-approved.
References
- Eli Lilly. Zepbound prescribing information (adverse reactions).
- Jastreboff AM et al. SURMOUNT-1. NEJM, 2022.
- American College of Cardiology. SURMOUNT-5 safety and GI discontinuation data. 2025.